Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05625399 |
|---|---|
| Brief Title: | A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma (RELATIVITY-127) |
| First Submitted : | November 15, 2022 |
| First Submitted that Met QC Criteria : | November 15, 2022 |
| First Posted : | November 22, 2022 |
| Last Update Submitted that Met QC Criteria : | May 10, 2024 |
| Last Update Posted : | May 13, 2024 |